Literature DB >> 5335690

Biogenic amines and emotion.

J J Schildkraut, S S Kety.   

Abstract

The studies discussed here have shown a fairly consistent relationship between the effects of drugs on biogenic amines, particularly norepinephrine, and affective or behavioral states. Those drugs which cause depletion and inactivation of norepinephrine centrally produce sedation or depression, while drugs which increase or potentiate brain norepinephrine are associated with behavioral stimulation or excitement and generally have an antidepressant effect in man (Table 1). From these findings, a number of investigators have formulated the concept, designated the catecholamine hypothesis of affective disorders (6), that some, if not all, depressions may be associated with a relative deficiency of norepinephrine at functionally important adrenergic receptor sites in the brain, whereas elations may be associated with an excess of such amines. It is not possible either to confirm or to reject this hypothesis on the basis of currently available clinical data. Although there does appear to be a fairly consistent relationship between the effects of pharmacological agents on norepinephrine metabolism and on affective state, a rigorous extrapolation from pharmacological studies to pathophysiology cannot be made. Confirmation of this hypothesis must ultimately depend upon direct demonstration of the biochemical abnormality in the naturally occurring illness. It should be emphasized, however, that the demonstration of such a biochemical abnormality would not necessarily imply a genetic or constitutional, rather than an environmental or psychological, etiology of depression. Whereas specific genetic factors may be of importance in the etiology of some, and possibly all, depressions, it is equally conceivable that early experiences of the infant or child may cause enduring biochemical changes and that these may predispose some individuals to depressions in adulthood. It is not likely that changes in the metabolism of the biogenic amines alone will account for the complex phenomena of normal or pathological affect. Whereas the effects of these amines at particular sites in the brain may be of crucial importance in the regulation of affect, any comprehensive formulation of the physiology of affective state will have to include many other concomitant biochemical, physiological, and psychological factors. Although in this review of the relationship of biogenic amines to affective state relatively little has been said concerning the intricate set of environmental and psychological determinants of emotion, the importance of these factors must be stressed. The normally occurring alterations in affective state induced by environmental events is well known to all, from personal experience. The interactions between such environmental determinants of affect, various physiological factors, and the complexity of psychological determinants, including cognitive factors derived from the individual's remote and immediate past experiences, have received only limited study under adequately controlled conditions. It may be anticipated, however, that this will prove to be a particularly fruitful area for future research, for only within such a multifactorial framework may one expect to understand fully the relationship of the biogenic amines to emotional state.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5335690     DOI: 10.1126/science.156.3771.21

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  88 in total

Review 1.  Neurochemistry and behavior in man.

Authors:  G S Omenn
Journal:  West J Med       Date:  1976-12

2.  The effect of dose, novelty, and exploration on amphetamine-produced stereotyped behavior.

Authors:  R L Russell; R O Pihl
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

3.  Amphetamine-induced changes in body temperature and glycogen content of the encephalon in the chicken.

Authors:  T K Hevor; P R Lehr; J Gayet
Journal:  Experientia       Date:  1975-06-15

4.  Psychic stress as a trigger of the spontaneous development and rupture of an aneurysm? A case report.

Authors:  W Müller-Forell; J Bohl
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

5.  Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain.

Authors:  Molly L Rovin; Katherine A Boss-Williams; Reid S Alisch; James C Ritchie; David Weinshenker; Charles H K West; Jay M Weiss
Journal:  Neuropeptides       Date:  2012-02-10       Impact factor: 3.286

6.  L-dopa and arousal.

Authors:  T B Horvath; R A Meares
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

7.  alpha-Adrenergic agents. 3. Behavioral effects of 2-aminotetralins.

Authors:  W C Holz; J P Hieble; C A Gill; R M DeMarinis; R G Pendleton
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Genetic regulation of neurotransmitter enzymes and receptors: relationship to the inheritance of psychiatric disorders.

Authors:  R D Ciaranello; R E Boehme
Journal:  Behav Genet       Date:  1982-02       Impact factor: 2.805

9.  Norepinephrine neuronal uptake binding sites in rat brain membranes labeled with [3H]desipramine.

Authors:  C M Lee; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

Review 10.  Drug-induced psychiatric disorders.

Authors:  D A Johnson
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.